Recursion Pharmaceuticals, Inc.
USD3.61
-0.18 (-4.75%)
CEO
Najat Khan
IPO Date
2021-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.68
Prev. Close
$3.79
Day Low
$3.57
Day High
$3.79
52W Low
$2.77
52W High
$7.18
Market Cap
$1.61B
Volume
20.66M
| 40,000 |
| $3.08 |
| 27 May 2026 | Gibson Christopher | director | C-Conversion | Disposed | 40,000 | $0.00 |
| 19 May 2026 | Hallett David | Chief Scientific Officer | F-InKind | Disposed | 26,657 | $3.04 |
| 19 May 2026 | Khan Najat | director, officer: CEO and President | F-InKind | Disposed | 62,701 | $3.04 |
| 19 May 2026 | Taylor Ben R | Chief Financial Officer | F-InKind | Disposed | 25,018 | $3.04 |
| 19 May 2026 | Gibson Christopher | director | F-InKind | Disposed | 22,821 | $3.04 |
| 8 May 2026 | Gibson Christopher | director | C-Conversion | Acquired | 60,000 | $0.00 |
| 8 May 2026 | Gibson Christopher | director | S-Sale | Disposed | 40,000 | $3.37 |
| 8 May 2026 | Gibson Christopher | director | G-Gift | Disposed | 20,000 | $0.00 |